Circadian regulation of m6A RNA methylation may explain why migraines follow daily patterns, offering potential for time-of-day-targeted therapies.
Circadian-m6A-migraine axisNovel hypothesis connecting body clock, RNA modifications, and migraine timing
What the researchers found
Circadian regulation of m6A RNA methylation may modulate neuronal excitability and pain signaling in migraine, explaining the well-known time-of-day patterns of attack onset.
Why it matters
Understanding why migraines strike at certain times could enable chronotherapy — timing medications or interventions to match when patients are most vulnerable.
How the study worked
Narrative review synthesizing evidence from chronobiology, neuroepigenetics, and migraine research.
What this study cannot tell us
Largely theoretical framework; direct evidence linking m6A circadian regulation to migraine onset in human patients is still lacking.
How to read the evidence
Hypothesis-generating narrative review — compelling framework but requires experimental validation.
When this study was published
Published in 2026, at the frontier of circadian epitranscriptomics in neurological disease.
The bigger picture
This bridges chronobiology and epigenetics in migraine, potentially explaining not just when attacks occur but opening new therapeutic targets at the intersection of circadian biology and RNA regulation.
Questions still open
- Could drugs targeting m6A methylation machinery be timed to prevent migraine attacks during vulnerable circadian windows?
- Do shift workers have altered m6A patterns that explain their higher migraine risk?
Common questions
Why do migraines often strike at the same time of day?
What is m6A RNA methylation?
Read the original research
Circadian Regulation of m6A RNA Methylation in Migraine: Mechanisms and Therapeutic Implications.
Journal of molecular neuroscience : MN, 76(1), 12
Citation
Chauhan, Shikha Baghel; Bhandari, Ayushi; Jain, Chirag; Singh, Indu. (2026). Circadian Regulation of m6A RNA Methylation in Migraine: Mechanisms and Therapeutic Implications.. Journal of molecular neuroscience : MN, 76(1), 12. https://doi.org/10.1007/s12031-025-02468-8